Delivery Order 75F40121D00009-75F40123F19003
Award Date 6/8/23
Potential Completion Date 6/14/24
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order against a broader Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The contract is for the purchase of $33,904.98 in molecular biology reagents. This order falls under the QIAGEN IDIQ, a multi-year, agency-wide IDC that enables the FDA to place recurring orders for specialized scientific consumables and equipment as needed. The...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The $35,320.14 order is for the purchase of molecular biology reagents under an Indefinite Delivery Vehicle (IDIQ) contract. The work will be performed in Silver Spring, Maryland. No set-aside designation was used for this award. Qiagen is a critical supplier of advanced scientific technologies to numerous...
- The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Delivery Order contract to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The $149,040.91 contract has a completion date of September 26, 2022. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has previously provided products and services like DNA/RNA extraction kits,...
- This is a federal contract award to Qiagen, LLC, a division of the biotechnology company Qiagen N.V. The contract, awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), has a ceiling value of $107,401.82 and is a firm fixed-price purchase order with an ultimate completion date of August 22, 2019. The contract provides for the addition of funding to an original requisition, without any set-aside designation. Qiagen, a...
- This is a delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $27,299.50 firm fixed price contract does not have a set-aside designation. Qiagen has provided a range of goods and services to support federal biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing,...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...
- This federal contract award was made by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the purchase of scientific consumables, such as DNA/RNA extraction kits, next-generation sequencing equipment, and bioinformatics software, with a ceiling value of $6,162.64. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Qiagen's ability to compete effectively in the federal...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
- This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...